D025601Chemicals & DrugsD05.500.117.249D12.776.220.040D12.776.476.081.249D12.776.624.776.049350.993828Adenomatous Polyposis Coli Proteincmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson11212243Wetmore C, Eberhart DE, Curran TCancer researchWetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 2001 Jan 15; 61(2):513-6.Cancer Res2001-01-15T00:00:002001Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.MD, PhDTomiPastinenTomi Pastinen0.000000000000000.00000000000000113Pastinen, TomiDirector, Center for Pediatric Genomic Medicine 1Professor21190457Rio Frio T, Lavoie J, Hamel N, Geyer FC, Kushner YB, Novak DJ, Wark L, Capelli C, Reis-Filho JS, Mai S, Pastinen T, Tischkowitz MD, Marcus VA, Foulkes WDThe New England journal of medicineRio Frio T, Lavoie J, Hamel N, Geyer FC, Kushner YB, Novak DJ, Wark L, Capelli C, Reis-Filho JS, Mai S, Pastinen T, Tischkowitz MD, Marcus VA, Foulkes WD. Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia. N Engl J Med. 2010 Dec 30; 363(27):2628-37.N Engl J Med2010-12-30T00:00:002010Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia.1.049290.0248193research area of0.6605680.0501035subject area forMD, FAAP, FACGThomasAttardThomas M. Attard0.000000000000000.00000000000000132Attard, ThomasMedical Director Polyposis Center17238184Attard TM, Giglio P, Koppula S, Snyder C, Lynch HTCancerAttard TM, Giglio P, Koppula S, Snyder C, Lynch HT. Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer. 2007 Feb 15; 109(4):761-6.Cancer2007-02-15T00:00:002007Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.27056662Septer S, Lawson CE, Anant S, Attard TFamilial cancerSepter S, Lawson CE, Anant S, Attard T. Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. Fam Cancer. 2016 07; 15(3):477-85.Fam Cancer2016-07-01T00:00:002016Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.28887722Septer S, Bohaty B, Onikul R, Kumar V, Williams KB, Attard TM, Friesen CA, Friesen LRFamilial cancerSepter S, Bohaty B, Onikul R, Kumar V, Williams KB, Attard TM, Friesen CA, Friesen LR. Dental anomalies in pediatric patients with familial adenomatous polyposis. Fam Cancer. 2018 04; 17(2):229-234.Fam Cancer2018-04-01T00:00:002018Dental anomalies in pediatric patients with familial adenomatous polyposis.MDCraigFriesenCraig A. Friesen0.000000000000000.00000000000000149Friesen, CraigAssociate Division Director, GastroenterologyPediatricsClinicalChildren's Mercy Kansas Citytrue1Medical Director Polyposis CenterMedical Director Polyposis Centertrue1Director, Center for Pediatric Genomic Medicine Director, Center for Pediatric Genomic Medicine true1Associate Division Director, GastroenterologyAssociate Division Director, Gastroenterology